• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绿茶和表没食子儿茶素没食子酸酯(EGCG)用于非酒精性脂肪性肝病(NAFLD)的管理:对氧化应激和抗氧化机制作用的见解

Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism.

作者信息

Tang Guoyi, Xu Yu, Zhang Cheng, Wang Ning, Li Huabin, Feng Yibin

机构信息

School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong, China.

School of Public Health, Sun Yat-sen University, Guangzhou 510080, China.

出版信息

Antioxidants (Basel). 2021 Jul 5;10(7):1076. doi: 10.3390/antiox10071076.

DOI:10.3390/antiox10071076
PMID:34356308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8301033/
Abstract

Nonalcoholic fatty liver diseases (NAFLD) represent a set of liver disorders progressing from steatosis to steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma, which induce huge burden to human health. Many pathophysiological factors are considered to influence NAFLD in a parallel pattern, involving insulin resistance, oxidative stress, lipotoxicity, mitochondrial dysfunction, endoplasmic reticulum stress, inflammatory cascades, fibrogenic reaction, etc. However, the underlying mechanisms, including those that induce NAFLD development, have not been fully understood. Specifically, oxidative stress, mainly mediated by excessive accumulation of reactive oxygen species, has participated in the multiple NAFLD-related signaling by serving as an accelerator. Ameliorating oxidative stress and maintaining redox homeostasis may be a promising approach for the management of NAFLD. Green tea is one of the most important dietary resources of natural antioxidants, above which epigallocatechin gallate (EGCG) notably contributes to its antioxidative action. Accumulative evidence from randomized clinical trials, systematic reviews, and meta-analysis has revealed the beneficial functions of green tea and EGCG in preventing and managing NAFLD, with acceptable safety in the patients. Abundant animal and cellular studies have demonstrated that green tea and EGCG may protect against NAFLD initiation and development by alleviating oxidative stress and the related metabolism dysfunction, inflammation, fibrosis, and tumorigenesis. The targeted signaling pathways may include, but are not limited to, NRF2, AMPK, SIRT1, NF-κB, TLR4/MYD88, TGF-β/SMAD, and PI3K/Akt/FoxO1, etc. In this review, we thoroughly discuss the oxidative stress-related mechanisms involved in NAFLD development, as well as summarize the protective effects and underlying mechanisms of green tea and EGCG against NAFLD.

摘要

非酒精性脂肪性肝病(NAFLD)是一组从脂肪变性发展为脂肪性肝炎、纤维化、肝硬化和肝细胞癌的肝脏疾病,给人类健康带来巨大负担。许多病理生理因素被认为以平行模式影响NAFLD,包括胰岛素抵抗、氧化应激、脂毒性、线粒体功能障碍、内质网应激、炎症级联反应、纤维化反应等。然而,其潜在机制,包括那些诱导NAFLD发生发展的机制,尚未完全明确。具体而言,氧化应激主要由活性氧的过度积累介导,作为一个促进因素参与了多种与NAFLD相关的信号传导。减轻氧化应激并维持氧化还原稳态可能是管理NAFLD的一种有前景的方法。绿茶是天然抗氧化剂最重要的饮食来源之一,其中表没食子儿茶素没食子酸酯(EGCG)对其抗氧化作用有显著贡献。来自随机临床试验、系统评价和荟萃分析的累积证据表明,绿茶和EGCG在预防和管理NAFLD方面具有有益作用,且在患者中安全性可接受。大量动物和细胞研究表明,绿茶和EGCG可能通过减轻氧化应激及相关代谢功能障碍、炎症、纤维化和肿瘤发生来预防NAFLD的发生和发展。其靶向的信号通路可能包括但不限于NRF2、AMPK、SIRT1、NF-κB、TLR4/MYD88、TGF-β/SMAD和PI3K/Akt/FoxO1等。在本综述中,我们深入讨论了NAFLD发生发展中涉及的氧化应激相关机制,并总结了绿茶和EGCG对NAFLD的保护作用及潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2dc/8301033/174cd6cce493/antioxidants-10-01076-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2dc/8301033/f6a76d9d6e58/antioxidants-10-01076-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2dc/8301033/92650ffcf66b/antioxidants-10-01076-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2dc/8301033/174cd6cce493/antioxidants-10-01076-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2dc/8301033/f6a76d9d6e58/antioxidants-10-01076-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2dc/8301033/92650ffcf66b/antioxidants-10-01076-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2dc/8301033/174cd6cce493/antioxidants-10-01076-g003.jpg

相似文献

1
Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism.绿茶和表没食子儿茶素没食子酸酯(EGCG)用于非酒精性脂肪性肝病(NAFLD)的管理:对氧化应激和抗氧化机制作用的见解
Antioxidants (Basel). 2021 Jul 5;10(7):1076. doi: 10.3390/antiox10071076.
2
Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways.没食子酸表没食子儿茶素酯通过 TGF/SMAD、PI3 K/Akt/FoxO1 和 NF-κB 通路减轻非酒精性脂肪性肝病大鼠模型的纤维化、氧化应激和炎症。
Eur J Nutr. 2014 Feb;53(1):187-99. doi: 10.1007/s00394-013-0516-8. Epub 2013 Mar 21.
3
Potential Biological Effects of (-)-Epigallocatechin-3-gallate on the Treatment of Nonalcoholic Fatty Liver Disease.没食子酸表没食子儿茶素-3-没食子酸酯在治疗非酒精性脂肪性肝病中的潜在生物学效应。
Mol Nutr Food Res. 2018 Jan;62(1). doi: 10.1002/mnfr.201700483. Epub 2017 Oct 12.
4
Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21-AMPK pathway in mice fed a high fat diet.表没食子儿茶素-3-没食子酸酯通过缓解高脂饮食喂养小鼠的成纤维细胞生长因子21(FGF21)抵抗和促进FGF21-AMPK信号通路来改善肝损伤。
Diabetol Metab Syndr. 2022 Apr 13;14(1):53. doi: 10.1186/s13098-022-00823-y.
5
Epigallocatechin gallate alleviates high-fat diet-induced hepatic lipotoxicity by targeting mitochondrial ROS-mediated ferroptosis.表没食子儿没食子酸酯通过靶向线粒体活性氧介导的铁死亡减轻高脂饮食诱导的肝脏脂毒性。
Front Pharmacol. 2023 Mar 21;14:1148814. doi: 10.3389/fphar.2023.1148814. eCollection 2023.
6
Tea Polyphenol Epigallocatechin Gallate Protects Against Nonalcoholic Fatty Liver Disease and Associated Endotoxemia in Rats via Modulating Gut Microbiota Dysbiosis and Alleviating Intestinal Barrier Dysfunction and Related Inflammation.茶多酚表没食子儿茶素没食子酸酯通过调节肠道微生物群失调、减轻肠道屏障功能障碍及相关炎症,对大鼠非酒精性脂肪性肝病及相关内毒素血症具有保护作用。
J Agric Food Chem. 2024 Apr 12. doi: 10.1021/acs.jafc.3c04832.
7
Epigallocatechin Gallate Suppresses Inflammatory Responses by Inhibiting Toll-like Receptor 4 Signaling and Alleviates Insulin Resistance in the Livers of High-fat-diet Rats.表没食子儿茶素没食子酸酯通过抑制Toll样受体4信号通路抑制炎症反应并减轻高脂饮食大鼠肝脏中的胰岛素抵抗。
J Oleo Sci. 2020 May 2;69(5):479-486. doi: 10.5650/jos.ess19303. Epub 2020 Apr 13.
8
Epigallocatechin gallate alleviates non-alcoholic fatty liver disease through the inhibition of the expression and activity of Dipeptide kinase 4.没食子儿茶素没食子酸酯通过抑制二肽激酶 4 的表达和活性来缓解非酒精性脂肪性肝病。
Clin Nutr. 2024 Aug;43(8):1769-1780. doi: 10.1016/j.clnu.2024.06.018. Epub 2024 Jun 19.
9
Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota.没食子儿茶素没食子酸酯可预防非酒精性脂肪性肝炎,效果类似于绿茶提取物,而对肠道微生物群有不同的影响。
J Nutr Biochem. 2020 Oct;84:108455. doi: 10.1016/j.jnutbio.2020.108455. Epub 2020 Jun 20.
10
Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice.富含表没食子儿茶素-3-没食子酸酯的脱咖啡因绿茶提取物通过提高饮食诱导肥胖小鼠线粒体呼吸链复合物的活性来预防脂肪肝疾病。
J Nutr Biochem. 2015 Nov;26(11):1348-56. doi: 10.1016/j.jnutbio.2015.07.002. Epub 2015 Jul 26.

引用本文的文献

1
Toxins to treatments: Impact of environmental pollutants, gut microbiota, and natural compounds on non-alcoholic fatty liver disease progression.从毒素到治疗:环境污染物、肠道微生物群和天然化合物对非酒精性脂肪性肝病进展的影响
World J Hepatol. 2025 Aug 27;17(8):108772. doi: 10.4254/wjh.v17.i8.108772.
2
EGCG and Taurine Synergistically Ameliorate Lipid Metabolism Disorder by Modulating Gut Microbiota and PPARα/FAS Signaling Pathway.表没食子儿茶素没食子酸酯(EGCG)和牛磺酸通过调节肠道微生物群和PPARα/FAS信号通路协同改善脂质代谢紊乱。
Nutrients. 2025 Aug 9;17(16):2595. doi: 10.3390/nu17162595.
3
Reactive Oxygen Species as Key Molecules in the Pathogenesis of Alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease: Future Perspectives.

本文引用的文献

1
Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy.氧化应激在非酒精性脂肪性肝病发病机制中的作用:对预防和治疗的启示
Antioxidants (Basel). 2021 Jan 26;10(2):174. doi: 10.3390/antiox10020174.
2
Genistein Modulated Lipid Metabolism, Hepatic PPARγ, and Adiponectin Expression in Bilateral Ovariectomized Rats with Nonalcoholic Steatohepatitis (NASH).金雀异黄素对非酒精性脂肪性肝炎(NASH)双侧卵巢切除大鼠脂质代谢、肝脏过氧化物酶体增殖物激活受体γ(PPARγ)及脂联素表达的调节作用
Antioxidants (Basel). 2020 Dec 29;10(1):24. doi: 10.3390/antiox10010024.
3
Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade.
活性氧作为酒精性脂肪性肝病和非酒精性脂肪性肝病发病机制中的关键分子:未来展望
Curr Issues Mol Biol. 2025 Jun 17;47(6):464. doi: 10.3390/cimb47060464.
4
A Review on Novel Techniques Used for Drying Medicinal Plants and Its Applications.用于干燥药用植物的新技术及其应用综述。
Int J Biomater. 2025 Jul 9;2025:4533070. doi: 10.1155/ijbm/4533070. eCollection 2025.
5
Nutraceutical Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Path to Liver Health.代谢功能障碍相关脂肪性肝病(MASLD)的营养治疗策略:通往肝脏健康之路
Nutrients. 2025 May 13;17(10):1657. doi: 10.3390/nu17101657.
6
Efficacy of dietary polyphenol supplement in patients with non-alcoholic fatty liver disease: a network meta-analysis.膳食多酚补充剂对非酒精性脂肪性肝病患者的疗效:一项网状Meta分析。
Front Nutr. 2025 May 9;12:1582861. doi: 10.3389/fnut.2025.1582861. eCollection 2025.
7
Green tea epigallocatechin gallate attenuate metabolic dysfunction-associated steatotic liver disease by regulation of pyroptosis.绿茶表没食子儿没食子酸酯通过调节细胞焦亡减轻代谢功能障碍相关脂肪性肝病。
Lipids Health Dis. 2025 May 17;24(1):180. doi: 10.1186/s12944-025-02596-5.
8
Unveiling p65 as the target of diphyllin in ameliorating metabolic dysfunction-associated steatotic liver disease via targeted protein degradation technology.通过靶向蛋白质降解技术揭示p65作为双叶豆素改善代谢功能障碍相关脂肪性肝病的靶点。
Front Pharmacol. 2025 Apr 28;16:1567639. doi: 10.3389/fphar.2025.1567639. eCollection 2025.
9
Potential Roles of Natural Antioxidants in Modulating Neurodegenerative Disease Pathways.天然抗氧化剂在调节神经退行性疾病通路中的潜在作用。
Mol Neurobiol. 2025 Apr 9. doi: 10.1007/s12035-025-04874-w.
10
Green tea polyphenol epigallocatechin-3-gallate mediates an antioxidant response via Nrf2 pathway in heat-stressed poultry: A review.绿茶多酚表没食子儿茶素-3-没食子酸酯通过Nrf2途径介导热应激家禽的抗氧化反应:综述
Poult Sci. 2025 May;104(5):105071. doi: 10.1016/j.psj.2025.105071. Epub 2025 Mar 20.
非酒精性脂肪性肝病的多重平行打击假说:十年后再审视
Hepatology. 2021 Feb;73(2):833-842. doi: 10.1002/hep.31518. Epub 2021 Feb 6.
4
Citrus reticulata Blanco peel extract ameliorates hepatic steatosis, oxidative stress and inflammation in HF and MCD diet-induced NASH C57BL/6 J mice.柑橘皮提取物可改善 HF 和 MCD 饮食诱导的 NASH C57BL/6 J 小鼠的肝脂肪变性、氧化应激和炎症。
J Nutr Biochem. 2020 Sep;83:108426. doi: 10.1016/j.jnutbio.2020.108426. Epub 2020 May 22.
5
Role of mast cells in the pathogenesis of liver fibrosis in nonalcoholic fatty liver disease.肥大细胞在非酒精性脂肪性肝病肝纤维化发病机制中的作用
Pol J Pathol. 2020;71(1):38-45. doi: 10.5114/pjp.2020.95414.
6
Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO Study.普通人群中非酒精性脂肪性肝病和晚期肝纤维化的患病率及危险因素:法国全国性NASH-CO研究
Gastroenterology. 2020 Aug;159(2):791-793.e2. doi: 10.1053/j.gastro.2020.04.048. Epub 2020 May 4.
7
Nonalcoholic Steatohepatitis: A Review.非酒精性脂肪性肝炎:综述。
JAMA. 2020 Mar 24;323(12):1175-1183. doi: 10.1001/jama.2020.2298.
8
Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease.氧化应激在非酒精性脂肪性肝病发病机制中的作用。
Free Radic Biol Med. 2020 May 20;152:116-141. doi: 10.1016/j.freeradbiomed.2020.02.025. Epub 2020 Mar 8.
9
The In Vivo Antioxidant and Hepatoprotective Actions of Selected Chinese Teas.几种中国茶的体内抗氧化和肝脏保护作用。
Foods. 2020 Mar 2;9(3):262. doi: 10.3390/foods9030262.
10
Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized clinical trials.绿茶或儿茶素对健康人群和非酒精性脂肪性肝病患者肝酶的影响:系统评价和随机临床试验荟萃分析。
Phytother Res. 2020 Jul;34(7):1587-1598. doi: 10.1002/ptr.6637. Epub 2020 Feb 18.